Supreme Court of India Criticizes Exorbitant Health System Profit Margins
What happened
The Supreme Court of India recently observed that the health system exhibits excessive pricing and profit margins on several medicines, describing the practice as "rampage, carnage, broad daylight dacoity". The court cited an example where patients were charged about nine times the normal price for a cancer medicine. Separately, Sandeep Jauhar continues to write for the New York Times.
From countercurrents.org
Why it matters
The court's observation highlights how the increasing profit orientation of the health system, driven by big business interests, may violate essential interests of patients. The report notes that costs can be even higher in countries like India due to the lower economic and social security levels of most patients.
From countercurrents.org
Who's involved
- Supreme Court of IndiaMade observations regarding exorbitant pricing and profit margins within the health system.
- Sandeep JauharAuthor of 'Doctored – The Disillusionment of an American Physician' and contributor to the New York Times.
- New York TimesPublishes articles written by Sandeep Jauhar.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Supreme Court of IndiaSpeculative
Patients might face higher costs for essential medicines due to the high profit margins observed in the health system.
Keep exploring
The entities involved
-
Supreme Court of India
Highest court of jurisdiction in the Republic of India
-
Sandeep Jauhar
Indian-American cardiologist and author
Nothing else this week.
-
New York Times
2001 album by Adam Bomb